Theories and definitions of tumors

Section 2.1 addresses the age-old question of “exactly what is a tumor, and how are they different from other swellings in the body?” Sections 2.2 and 2.3 give accounts of views on this question, especially after the description of cell theory (1839), and also show how much of the current terminology of tumor pathology was developed at this time. Sections 2.4–2.8 describe the full chronology of “somatic mutation” theories of tumors to the present time. Section 2.9 details other theories and related concepts of tumors. Section 2.10 is concerned with current attempts to define malignant tumors, while Section 2.11 points out that published considerations of tumors have paid little attention to the fact that tumors occur in significantly different types, but all from the one genome.

• Publication year

  2020

• Venue

  Principles of Tumors

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-12-801565-0.00002-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor Immunity

  2020cited by this paper
• The Vascular Morphology of Tumors

  2020cited by this paper
• SUN-308 The Combinatory Effects of Estradiol and Tumor Derived Factors on Myeloid Cell Differentiation in Lymphangioleiomyomatosis (LAM)

  2020cited by this paper
• The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective

  2019cited by this paper
• Cancer and inflammation

  2017cited by this paper
• The Role of Oxysterols in Human Cancer.

  2017cited by this paper
• Evolutionary dynamics and significance of multiple subclonal mutations in cancer.

  2017cited by this paper
• The opposing roles of laminin-binding integrins in cancer.

  2017cited by this paper
• Cadherin-mediated cell-cell interactions in normal and cancer cells

  2017cited by this paper
• Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.

  2017cited by this paper
• The Elephant in the Room: The Role of Microtubules in Cancer.

  2017cited by this paper
• The discovery of the lymphatic system in the seventeenth century. Part II: the discovery of Chyle vessels

  2016cited by this paper
• Broad targeting of angiogenesis for cancer prevention and therapy

  2015cited by this paper
• Targeted p16(Ink4a) epimutation causes tumorigenesis and reduces survival in mice.

  2014cited by this paper
• Molecular mechanisms of epithelial–mesenchymal transition

  2014cited by this paper
• DNA methylation changes in inflammatory bowel disease

  2014cited by this paper
• Viruses and Human Cancers: a Long Road of Discovery of Molecular Paradigms

  2014cited by this paper
• The promise and failures of epigenetic therapies for cancer treatment.

  2014cited by this paper
• Virus infection, inflammation and prevention of cancer.

  2014cited by this paper
• The role of imprinted genes in humans.

  2013cited by this paper
• Tyrosine kinase gene rearrangements in epithelial malignancies

  2013cited by this paper
• Cancer Genome Landscapes

  2013cited by this paper
• Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.

  2013cited by this paper
• DNA methylation dynamics during the mammalian life cycle

  2013cited by this paper
• Tumors of the testis and adjacent structures

  2013cited by this paper
• Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms

  2013cited by this paper
• Epigenetic changes during cell transformation.

  2013cited by this paper
• DNA hypomethylation and hemimethylation in cancer.

  2013cited by this paper
• Clonal evolution in cancer

  2012cited by this paper
• Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases.

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Histone deacetylases and cancer

  2012cited by this paper
• Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.

  2012cited by this paper
• The early history of tumor virology: Rous, RIF, and RAV

  2011cited by this paper
• Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation?

  2011cited by this paper
• Human cancers express mutator phenotypes: origin, consequences and targeting

  2011cited by this paper
• Basic concepts of inflammation and its role in carcinogenesis.

  2011cited by this paper
• Cytogenetic analysis of tumor clonality.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Role of telomeres and telomerase in cancer.

  2011cited by this paper
• Cancer as a reprogramming-like disease: implications in tumor development and treatment.

  2010cited by this paper
• What are the hallmarks of cancer?

  2010cited by this paper
• Interactions between nuclei and the cytoskeleton are mediated by SUN-KASH nuclear-envelope bridges.

  2010cited by this paper
• Epigenetics in cancer.

  2010cited by this paper
• The Hox genes and their roles in oncogenesis

  2010cited by this paper
• Normal and pathological V(D)J recombination: contribution to the understanding of human lymphoid malignancies.

  2009cited by this paper
• The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies

  2009cited by this paper
• Angiogenesis Protocols

  2009cited by this paper
• Field effect in cancer-an update.

  2009cited by this paper
• Down syndrome: Comments and reflections on the 50th anniversary of Lejeune's discovery

  2009cited by this paper
• Genotoxicity: damage to DNA and its consequences.

  2009cited by this paper
• The history of tumor virology.

  2008cited by this paper
• Modes of resistance to anti-angiogenic therapy

  2008cited by this paper
• Many different tumor types have polyclonal tumor origin: evidence and implications.

  2008cited by this paper
• Telomere dysfunction, genome instability and cancer.

  2008cited by this paper
• Inflammation: gearing the journey to cancer.

  2008cited by this paper
• Virchow's "cellular pathology" 150 years later.

  2008cited by this paper
• Concerning the Origin of Malignant Tumours by Theodor Boveri. Translated and annotated by Henry Harris

  2008cited by this paper
• c-Myc: linking transformation and genomic instability.

  2008cited by this paper
• Expansion of a mutated clone: from stem cell to tumour

  2007cited by this paper
• Stem Cells and Tumourigenesis

  2007cited by this paper
• Epigenetics and the plasticity of differentiation in normal and cancer stem cells

  2006cited by this paper
• Hansemann, Boveri, chromosomes and the gametogenesis‐related theories of tumours

  2006cited by this paper
• Cancer morphology, carcinogenesis and genetic instability: a background.

  2006cited by this paper
• In Vitro Transformation Models: Modeling Human Cancer

  2006cited by this paper
• Aneuploidy, stem cells and cancer.

  2006cited by this paper
• Cancer Stem Cells and Differentiation Therapy

  2006cited by this paper
• The epigenetic progenitor origin of human cancer

  2006cited by this paper
• Redefining the risks of prenatally ascertained supernumerary marker chromosomes: a collaborative study

  2006cited by this paper
• Detection of chromosomal aberrations by comparative genomic hybridization during transformation of human breast epithelial cells in vitro.

  2006cited by this paper
• Carcinogenic polycyclic aromatic hydrocarbon‐DNA adducts and mechanism of action

  2005cited by this paper
• Embryonic reversions and lineage infidelities in tumour cells: genome‐based models and role of genetic instability

  2005cited by this paper
• Emergentism as a default: Cancer as a problem of tissue organization

  2005cited by this paper
• Allgemeine Pathologie

  2005cited by this paper
• Genetic instability in cancer: theory and experiment.

  2005cited by this paper
• An analysis of a wrong Nobel Prize-Johannes Fibiger, 1926: a study in the Nobel archives.

  2004cited by this paper
• Chaotic Genomes Make Chaotic Cells: The Mutator Phenotype Theory of Carcinogenesis Applied to Clinicopathological Relationships of Solid Tumors

  2004cited by this paper
• The three Es of cancer immunoediting.

  2004cited by this paper
• Initiation of genetic instability and tumour formation: a review and hypothesis of a nongenotoxic mechanism

  2003cited by this paper
• A short history of the polymerase chain reaction.

  2003cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Selective clonal expansion and microenvironmental permissiveness in tobacco carcinogenesis

  2002cited by this paper
• Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study

  2002cited by this paper
• Single nucleotide polymorphisms : methods and protocols

  2002cited by this paper
• Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

  2002cited by this paper
• A mutator phenotype in cancer.

  2001cited by this paper
• Significance of multiple mutations in cancer.

  2000cited by this paper
• Development of Human Cell Lines from Multiple Organs

  2000cited by this paper
• Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament: Atlas of Tumor Pathology

  1999cited by this paper
• The onset and extent of genomic instability in sporadic colorectal tumor progression.

  1999cited by this paper
• Molecular aspects of neoplasia of Syrian hamster cells transformed in vitro by chemical carcinogens.

  1998cited by this paper
• Many mutations in cancers.

  1996cited by this paper
• Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis.

  1996cited by this paper
• The origins of the clonal selection theory of immunity as a case study for evaluation in science

  1995cited by this paper
• The multistep nature of cancer.

  1993cited by this paper
• Cytoskeleton--plasma membrane interactions.

  1992cited by this paper
• Cancer, chromosomes, and genes.

  1992cited by this paper
• The SCID mouse mutant: definition, characterization, and potential uses.

  1991cited by this paper
• [Insulin-like growth factors].

  1990cited by this paper
• The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture.

  1988cited by this paper

• No citing papers are available for this paper.